NEWS
The ACI to Partner with VOXPO for B2C and B2B CBD Event
The ACI will host a series of panels at the upcoming VOXPO virtual event which runs from July 31 to August 2. The ACI are educational partners for the event and our panels will discuss issues relevant to CBD companies and consumers. The panels will draw upon our in-house experts and representatives of brands that […]
The post The ACI to Partner with VOXPO for B2C and B2B CBD Event appeared first on The ACI – Association for the Cannabinoid Industry.
The ACI will host a series of panels at the upcoming VOXPO virtual event which runs from July 31 to August 2. The ACI are educational partners for the event and our panels will discuss issues relevant to CBD companies and consumers.
The panels will draw upon our in-house experts and representatives of brands that make up the ACI membership and will educate CBD business and consumers. In addition to these panel sessions The ACI will staff a virtual stand where companies and consumers can drop by to ask questions.
The panels will be as follows.
Novel Foods Session
The ACI’s team of regulatory experts will discuss the upcoming Novel Foods deadline that affects all ingestible CBD on sale in the UK. They will explore how CBD companies can prepare their novel foods dossier, the content requirements for these dossiers including organising safety studies, and how companies can sustain quality standards for their products.
Chair: Dr Parveen Bhatarah, Regulatory and Compliance Lead, The ACI
Panel:
Isabel Alber – Regulatory and Compliance Consultant, The ACI
Marc Burbidge – Development and Quality Lead, The ACI
CBD Certification Session
The ACI team and members of the ACI explain how the ACI’s pioneering Certification program can support a safe and compliant CBD industry. We’ll look at how CBD companies can demonstrate to consumers that they are taking their safety seriously.
Chair: Shomi Malik, Development Director, The ACI
Panel:
Isabel Alber – Regulatory and Compliance Consultant, The ACI
Marc Burbidge – Development and Quality Lead, The ACI
Joe Seaman – Head of Regulatory Compliance, CBD Capital
Kamila Laura Sitwell – Co-Founder, Kolibri Drinks
Everything You Wanted to Know About CBD But Didn’t Like to Ask Session
How can you ensure that the CBD you are consuming is safe and legal? The ACI team and ACI members discuss the upcoming legal changes to selling CBD and the steps you can take now to choose your CBD wisely.
Chair: Bill Griffin, Media Lead, The ACI
Panel:
Haseeb Bani – Director of Research and Development, B3 Labs
Joseph Colliver – CFO, Sativa Group
Moyra Cosgrove – Head of Nutrition, Naturecan
The Future of Cannabinoids Session
Join the ACI and ACI members to explore how the CBD and cannabinoid market is predicted to develop, how we can be innovative as well as ensuring safety for consumers and ultimately how we can make the most of these remarkable cannabinoids.
Chair: Marc Burbidge, Development and Quality Lead, The ACI
Panel:
Dr Parveen Bhatarah – Dr Parveen Bhatarah, Regulatory and Compliance Lead, The ACI
Filipp Korentsvit – Co-Founder and Co-CEO, Weedworks
Rosemary Mazanet – Chief Scientific Officer, Columbia Care
Nick Pateras – Managing Director, Europe, Materia Ventures
Angus Taylor – CEO, Infused Product International
Date: July 31 to August 2 2020
Where: Online
Cost: Free
The post The ACI to Partner with VOXPO for B2C and B2B CBD Event appeared first on The ACI – Association for the Cannabinoid Industry.
